Melanoma targeted NGS panel-Pathology add-on

Test info

Melanoma targeted NGS panel
Pathology add-on
Hot spot mutations
Next Generation Sequencing
Oncomine focus assay
  • BRAF
  • KIT
  • NRAS
  • GNA11
  • GNAQ

Next Generation Sequencing (NGS) for the detection of alterations in solid tumors is critical for cancer care as these findings can direct the optimal use of targeted therapies for patients.


If blocks more than 5 years old are submitted for testing, extraction will be attempted, but if insufficient RNA/DNA is retrieved, testing will be cancelled


Tumor tissue

Formalin-fixed paraffin-embedded (FFPE) tissue block


Cytology slide


Molecular Medicare billing request

Hospital clients submitting a request for this assay on an outpatient with Medicare should complete and submit a Molecular Medical billing request form along with the sample.

  • Complete and submit the form to notify us of the need for Allina Health Laboratory to bill insurance for Molecular testing performed
  • All information requested is required in order for your request to be completed



AHL - Molecular Diagnostics: D
10 business days

Next Generation Sequencing

Clinical and Interpretive info


No variations detected


This test may require preauthorization from the insurance provider. Check the payer guidelines and, if needed, obtain the pre-authorization prior to sample collection.
81445 - NGS: targeted genomic sequence analysis panel, solid organ 5 - 50 genes